vs

Side-by-side financial comparison of Definitive Healthcare Corp. (DH) and Phathom Pharmaceuticals, Inc. (PHAT). Click either name above to swap in a different company.

Definitive Healthcare Corp. is the larger business by last-quarter revenue ($61.5M vs $57.6M, roughly 1.1× Phathom Pharmaceuticals, Inc.). On growth, Phathom Pharmaceuticals, Inc. posted the faster year-over-year revenue change (94.1% vs -1.2%). Definitive Healthcare Corp. produced more free cash flow last quarter ($-1.7M vs $-167.0M).

Prestige Consumer Healthcare Inc. is an American company that markets and distributes over-the-counter healthcare and household cleaning products. It was formed by the merger of Medtech Products, Inc., Prestige Brands International, and the Spic and Span Company in 1996. The company is headquartered in Tarrytown, New York and operates a manufacturing facility in Lynchburg, Virginia.

Phathom Pharmaceuticals is a clinical-stage biopharmaceutical firm focused on developing and commercializing innovative therapies for gastrointestinal diseases. Its lead product candidates address acid-related disorders, inflammatory bowel disease, and other GI conditions, serving patients mainly across North America and Europe.

DH vs PHAT — Head-to-Head

Bigger by revenue
DH
DH
1.1× larger
DH
$61.5M
$57.6M
PHAT
Growing faster (revenue YoY)
PHAT
PHAT
+95.3% gap
PHAT
94.1%
-1.2%
DH
More free cash flow
DH
DH
$165.3M more FCF
DH
$-1.7M
$-167.0M
PHAT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
DH
DH
PHAT
PHAT
Revenue
$61.5M
$57.6M
Net Profit
$-9.3M
Gross Margin
76.2%
86.7%
Operating Margin
-43.3%
Net Margin
-15.1%
Revenue YoY
-1.2%
94.1%
Net Profit YoY
84.2%
71.6%
EPS (diluted)
$-0.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DH
DH
PHAT
PHAT
Q4 25
$61.5M
$57.6M
Q3 25
$60.0M
$49.5M
Q2 25
$60.8M
$39.5M
Q1 25
$59.2M
$28.5M
Q4 24
$62.3M
$29.7M
Q3 24
$62.7M
$16.4M
Q2 24
$63.7M
$7.3M
Q1 24
$63.5M
Net Profit
DH
DH
PHAT
PHAT
Q4 25
$-9.3M
Q3 25
$-14.8M
$-30.0M
Q2 25
$-7.6M
$-75.8M
Q1 25
$-107.2M
$-94.3M
Q4 24
$-59.1M
Q3 24
$-130.9M
$-85.6M
Q2 24
$-213.6M
$-91.4M
Q1 24
$-9.5M
Gross Margin
DH
DH
PHAT
PHAT
Q4 25
76.2%
86.7%
Q3 25
76.6%
87.5%
Q2 25
76.7%
87.2%
Q1 25
73.9%
86.9%
Q4 24
76.4%
87.1%
Q3 24
78.2%
85.6%
Q2 24
79.2%
81.2%
Q1 24
79.4%
Operating Margin
DH
DH
PHAT
PHAT
Q4 25
-43.3%
Q3 25
-14.5%
-30.8%
Q2 25
-6.9%
-151.7%
Q1 25
-312.2%
-276.5%
Q4 24
-159.8%
Q3 24
-359.5%
-433.0%
Q2 24
-579.9%
-1055.4%
Q1 24
-25.6%
Net Margin
DH
DH
PHAT
PHAT
Q4 25
-15.1%
Q3 25
-24.7%
-60.5%
Q2 25
-12.4%
-191.9%
Q1 25
-181.2%
-330.7%
Q4 24
-94.8%
Q3 24
-208.8%
-523.3%
Q2 24
-335.2%
-1248.6%
Q1 24
-15.0%
EPS (diluted)
DH
DH
PHAT
PHAT
Q4 25
$-0.14
Q3 25
$-0.14
$-0.41
Q2 25
$-0.07
$-1.05
Q1 25
$-0.95
$-1.31
Q4 24
$-0.53
Q3 24
$-1.12
$-1.32
Q2 24
$-1.81
$-1.56
Q1 24
$-0.08

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DH
DH
PHAT
PHAT
Cash + ST InvestmentsLiquidity on hand
$180.9M
$130.0M
Total DebtLower is stronger
$156.1M
$209.1M
Stockholders' EquityBook value
$379.0M
$-438.2M
Total Assets
$735.5M
$259.1M
Debt / EquityLower = less leverage
0.41×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DH
DH
PHAT
PHAT
Q4 25
$180.9M
$130.0M
Q3 25
$185.9M
$135.2M
Q2 25
$184.2M
$149.6M
Q1 25
$200.7M
$212.3M
Q4 24
$290.2M
$297.3M
Q3 24
$305.4M
$334.7M
Q2 24
$296.5M
$276.2M
Q1 24
$295.2M
Total Debt
DH
DH
PHAT
PHAT
Q4 25
$156.1M
$209.1M
Q3 25
$158.2M
$207.1M
Q2 25
$160.3M
$205.1M
Q1 25
$162.4M
$203.2M
Q4 24
$229.4M
$201.4M
Q3 24
$232.7M
$175.7M
Q2 24
$236.0M
$174.4M
Q1 24
$239.3M
Stockholders' Equity
DH
DH
PHAT
PHAT
Q4 25
$379.0M
$-438.2M
Q3 25
$389.7M
$-422.5M
Q2 25
$411.2M
$-405.8M
Q1 25
$435.9M
$-338.4M
Q4 24
$607.2M
$-253.6M
Q3 24
$695.6M
$-187.1M
Q2 24
$886.3M
$-233.8M
Q1 24
$1.2B
Total Assets
DH
DH
PHAT
PHAT
Q4 25
$735.5M
$259.1M
Q3 25
$755.5M
$240.3M
Q2 25
$770.1M
$250.2M
Q1 25
$808.7M
$294.2M
Q4 24
$1.1B
$378.3M
Q3 24
$1.2B
$387.0M
Q2 24
$1.4B
$319.4M
Q1 24
$1.8B
Debt / Equity
DH
DH
PHAT
PHAT
Q4 25
0.41×
Q3 25
0.41×
Q2 25
0.39×
Q1 25
0.37×
Q4 24
0.38×
Q3 24
0.33×
Q2 24
0.27×
Q1 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DH
DH
PHAT
PHAT
Operating Cash FlowLast quarter
$2.7M
$-166.8M
Free Cash FlowOCF − Capex
$-1.7M
$-167.0M
FCF MarginFCF / Revenue
-2.8%
-290.0%
Capex IntensityCapex / Revenue
7.2%
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$37.1M
$-328.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DH
DH
PHAT
PHAT
Q4 25
$2.7M
$-166.8M
Q3 25
$15.7M
$-14.1M
Q2 25
$9.3M
$-62.7M
Q1 25
$26.1M
$-84.9M
Q4 24
$8.1M
$-266.8M
Q3 24
$19.4M
$-63.6M
Q2 24
$14.0M
$-70.7M
Q1 24
$16.6M
Free Cash Flow
DH
DH
PHAT
PHAT
Q4 25
$-1.7M
$-167.0M
Q3 25
$13.4M
$-14.1M
Q2 25
$7.0M
$-62.8M
Q1 25
$18.4M
$-84.9M
Q4 24
$-2.8M
$-266.9M
Q3 24
$18.7M
$-63.6M
Q2 24
$13.6M
$-70.8M
Q1 24
$16.3M
FCF Margin
DH
DH
PHAT
PHAT
Q4 25
-2.8%
-290.0%
Q3 25
22.3%
-28.6%
Q2 25
11.5%
-159.0%
Q1 25
31.0%
-297.9%
Q4 24
-4.4%
-899.8%
Q3 24
29.8%
-389.0%
Q2 24
21.4%
-966.2%
Q1 24
25.7%
Capex Intensity
DH
DH
PHAT
PHAT
Q4 25
7.2%
0.4%
Q3 25
3.8%
0.1%
Q2 25
3.8%
0.2%
Q1 25
13.0%
0.1%
Q4 24
17.5%
0.5%
Q3 24
1.2%
0.3%
Q2 24
0.6%
0.6%
Q1 24
0.4%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DH
DH

Subscription Services$58.5M95%
Professional Services$3.0M5%

PHAT
PHAT

Segment breakdown not available.

Related Comparisons